JP Morgan Chase
IRON icon

JP Morgan Chase’s Disc Medicine IRON Stock Holding History

JP Morgan Chase’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140M Buy
1,875,795
+504,315
+37% +$34.7M 0.01% 906
2026
Q1 		$83.4M Sell
1,371,480
-209,647
-13% -$14.5M 0.01% 1074
2025
Q4 		$126M Buy
1,581,127
+828,248
+110% +$70M 0.01% 841
2025
Q3 		$49.8M Sell
752,879
-90,737
-11% -$5.4M ﹤0.01% 1418
2025
Q2 		$44.7M Buy
843,616
+84,278
+11% +$3.96M ﹤0.01% 1394
2025
Q1 		$37.7M Buy
759,338
+698,321
+1,144% +$38.8M ﹤0.01% 1477
2024
Q4 		$3.87M Buy
61,017
+44,762
+275% +$2.59M ﹤0.01% 3594
2024
Q3 		$799K Buy
16,255
+2,257
+16% +$106K ﹤0.01% 4610
2024
Q2 		$631K Buy
13,998
+1,725
+14% +$58.6K ﹤0.01% 4551
2024
Q1 		$764K Sell
12,273
-3,756
-23% -$244K ﹤0.01% 4527
2023
Q4 		$926K Buy
16,029
+9,997
+166% +$512K ﹤0.01% 4384
2023
Q3 		$283K Buy
6,032
+35
+0.6% +$1.75K ﹤0.01% 4833
2023
Q2 		$266K Buy
+5,997
New +$213K ﹤0.01% 4902
2023
Q1 		– Sell
-1
Closed – – 6965
2022
Q4 		$0 Buy
+1
New +$50 ﹤0.01% 6771
2022
Q2 		– Sell
-342
Closed -$14K – 6674
2022
Q1 		$14K Sell
342
-10
-3% -$524 ﹤0.01% 6142
2021
Q4 		$30K Sell
352
-417
-54% -$40.9K ﹤0.01% 6112
2021
Q3 		$93K Buy
769
+489
+175% +$66.8K ﹤0.01% 5603
2021
Q2 		$54K Buy
280
+180
+180% +$59.2K ﹤0.01% 5713
2021
Q1 		$41K Buy
+100
New +$44.6K ﹤0.01% 5578

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

JP Morgan Chase's IRON Position: Q2 2026 in Review

JP Morgan Chase increased its Disc Medicine (IRON) stake by 37% in Q2 2026, buying an estimated $34.7M and bringing the position to 1,875,795 shares worth $140M. The position accounts for 0.01% of the portfolio, ranked #906.

JP Morgan Chase first reported a position in IRON in Q1 2021 and has held it in 19 quarters since. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • JP Morgan Chase held 1,875,795 shares of Disc Medicine worth $140M as of Q2 2026.
  • JP Morgan Chase bought 504,315 Disc Medicine shares in Q2 2026, an estimated $34.7M.
  • Disc Medicine made up 0.01% of JP Morgan Chase's portfolio in Q2 2026, its #906 holding.
  • JP Morgan Chase first reported a position in Disc Medicine in Q1 2021 and has held it in 19 quarters since.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.